Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,078
archived clinical trials in
Major Depression Disorder (MDD)

Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Midwest Clinical Research Center
mi
from
Dayton, OH
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Midwest Clinical Research Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
IPS Research Company
mi
from
Oklahoma City, OK
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
IPS Research Company
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Clinical Neuroscience Solutions, Inc. - Memphis
mi
from
Memphis, TN
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Clinical Neuroscience Solutions, Inc. - Memphis
mi
from
Memphis, TN
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Noesis Pharma
mi
from
Phoenix, AZ
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Noesis Pharma
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Collaborative Neuroscience Network, Inc. - Garden Grove
mi
from
Garden Grove, CA
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Collaborative Neuroscience Network, Inc. - Garden Grove
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Pacific Institute for Medical Research Inc
mi
from
Los Angeles, CA
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Pacific Institute for Medical Research Inc
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Pacific Research Partners, LLC
mi
from
Oakland, CA
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Pacific Research Partners, LLC
mi
from
Oakland, CA
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Collaborative Neuroscience Network, Inc. - Torrance
mi
from
Torrance, CA
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Collaborative Neuroscience Network, Inc. - Torrance
mi
from
Torrance, CA
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Pacific Clinical Research Medical Group
mi
from
Upland, CA
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Pacific Clinical Research Medical Group
mi
from
Upland, CA
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Florida Clinical Research Center, LLC - Bradenton
mi
from
Bradenton, FL
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Florida Clinical Research Center, LLC - Bradenton
mi
from
Bradenton, FL
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Florida Clinical Research Center, LLC - Maitland
mi
from
Maitland, FL
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Florida Clinical Research Center, LLC - Maitland
mi
from
Maitland, FL
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Boston Clinical Trials, INC.
mi
from
Boston, MA
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Boston Clinical Trials, INC.
mi
from
Boston, MA
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Thomas Jefferson University Mood Disorder Program
mi
from
Philadelphia, PA
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Thomas Jefferson University Mood Disorder Program
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
BioBehavioral Research of Austin
mi
from
Austin, TX
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
BioBehavioral Research of Austin
mi
from
Austin, TX
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
University of Virginia Center for Psychiatric Research
mi
from
Charlottesville, VA
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
University of Virginia Center for Psychiatric Research
mi
from
Charlottesville, VA
Click here to add this to my saved trials
MRI Studies of Emotion in Depression
Functional MRI Studies of Emotion in Depression and Rapid Antidepressant Response
Status: Enrolling
Updated:  4/5/2017
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
MRI Studies of Emotion in Depression
Functional MRI Studies of Emotion in Depression and Rapid Antidepressant Response
Status: Enrolling
Updated: 4/5/2017
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
San Diego, CA
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Atlanta, GA
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Baltimore, MD
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Houston, TX
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Chino, CA
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Chino, CA
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Research Site
mi
from
Lond Beach, CA
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Research Site
mi
from
Lond Beach, CA
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Stanford, CA
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Stanford, CA
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
New Heaven, CT
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
New Heaven, CT
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Ft. Lauderdale, FL
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Ft. Lauderdale, FL
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Gainsville, FL
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Gainsville, FL
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Lake City, FL
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Lake City, FL
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Miami, FL
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Orlando, FL
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
St Petersburg, FL
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
St Petersburg, FL
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Decatur, GA
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Hoffman Estates, IL
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Joliet, IL
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Joliet, IL
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Skokie, IL
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Skokie, IL
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Lake Charles, LA
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Lake Charles, LA
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Shreveport, LA
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Shreveport, LA
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Boston, MA
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Minneapolis, MN
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
St. Louis, MO
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Willingboro, NJ
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Willingboro, NJ
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Mount Kisco, NY
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Mount Kisco, NY
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
New York, NY
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Rochester, NY
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Winston-Salem, NC
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Cincinnati, OH
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Dayton, OH
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Dayton, OH
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Philadelphia, PA
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Dallas, TX
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials